These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 17158047)
21. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. Akula N; Lecanu L; Greeson J; Papadopoulos V Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234 [TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates. Fang L; Kraus B; Lehmann J; Heilmann J; Zhang Y; Decker M Bioorg Med Chem Lett; 2008 May; 18(9):2905-9. PubMed ID: 18406135 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents. Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959 [TBL] [Abstract][Full Text] [Related]
24. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase. Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549 [TBL] [Abstract][Full Text] [Related]
25. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease. Chen Y; Sun J; Peng S; Liao H; Zhang Y; Lehmann J Arch Pharm (Weinheim); 2013 Dec; 346(12):865-71. PubMed ID: 24203864 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease. Hamulakova S; Janovec L; Hrabinova M; Kristian P; Kuca K; Banasova M; Imrich J Eur J Med Chem; 2012 Sep; 55():23-31. PubMed ID: 22818849 [TBL] [Abstract][Full Text] [Related]
28. Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesterase. Evangelista TCS; López Ó; Ferreira SB; Fernández-Bolaños JG; Sydnes MO; Lindbäck E J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1659-1664. PubMed ID: 34294013 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of tacrine-thiadiazolidinone hybrids as dual acetylcholinesterase inhibitors. Dorronsoro I; Alonso D; Castro A; del Monte M; García-Palomero E; Martínez A Arch Pharm (Weinheim); 2005 Jan; 338(1):18-23. PubMed ID: 15674800 [TBL] [Abstract][Full Text] [Related]
30. New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease. Szymański P; Zurek E; Mikiciuk-Olasik E Pharmazie; 2006 Apr; 61(4):269-73. PubMed ID: 16649535 [TBL] [Abstract][Full Text] [Related]
31. Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases. Wang Y; Guan XL; Wu PF; Wang CM; Cao H; Li L; Guo XJ; Wang F; Xie N; Jiang FC; Chen JG J Med Chem; 2012 Apr; 55(7):3588-92. PubMed ID: 22420827 [TBL] [Abstract][Full Text] [Related]
32. Bis(7)-tacrine derivatives as multitarget-directed ligands: Focus on anticholinesterase and antiamyloid activities. Bolognesi ML; Bartolini M; Mancini F; Chiriano G; Ceccarini L; Rosini M; Milelli A; Tumiatti V; Andrisano V; Melchiorre C ChemMedChem; 2010 Aug; 5(8):1215-20. PubMed ID: 20486153 [No Abstract] [Full Text] [Related]
33. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. Gharaghani S; Khayamian T; Ebrahimi M SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease. Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors. Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370 [TBL] [Abstract][Full Text] [Related]
37. Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. Camps P; Muñoz-Torrero D Mini Rev Med Chem; 2001 Jul; 1(2):163-74. PubMed ID: 12369981 [TBL] [Abstract][Full Text] [Related]
38. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives. Zhang S; Hou B; Yang H; Zuo Z Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. Shao D; Zou C; Luo C; Tang X; Li Y Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, kinetic studies and molecular modeling of novel tacrine dimers as cholinesterase inhibitors. de Aquino RA; Modolo LV; Alves RB; de Fátima  Org Biomol Chem; 2013 Dec; 11(48):8395-409. PubMed ID: 24186541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]